Original Article

You have full text access to this OnlineOpen article

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia

  1. Merat Karbasian-Esfahani M.D.†,*,
  2. Peter H. Wiernik M.D.,
  3. Yelena Novik M.D.,
  4. Elisabeth Paietta Ph.D.,
  5. Janice P. Dutcher M.D.

Article first published online: 27 JUL 2004

DOI: 10.1002/cncr.20494

Issue

Cancer

Cancer

Volume 101, Issue 6, pages 1414–1419, 15 September 2004

Additional Information

How to Cite

Karbasian-Esfahani, M., Wiernik, P. H., Novik, Y., Paietta, E. and Dutcher, J. P. (2004), Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia. Cancer, 101: 1414–1419. doi: 10.1002/cncr.20494

Author Information

  1. Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New York Medical College, Bronx, New York

  1. †

    Fax: (718) 920-1123

*Our Lady of Mercy Cancer Center, 600 E.233rd Street, Bronx, NY 10466

Publication History

  1. Issue published online: 1 SEP 2004
  2. Article first published online: 27 JUL 2004
  3. Manuscript Accepted: 10 JUN 2004
  4. Manuscript Revised: 4 JUN 2004
  5. Manuscript Received: 1 APR 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (79K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter H. Wiernik, Acute Lymphoblastic Leukemia of Adulthood: Progress or Not?, Current Treatment Options in Oncology, 2011, 12, 4, 303

    CrossRef

  2. 2
    Merat Karbasian-Esfahani, Peter H. Wiernik, Mrilini Yeddu, Lool Abebe, Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL), Hematology, 2008, 13, 2, 101

    CrossRef

  3. 3
    Alessandra Tedeschi, Marco Montillo, Elena Strocchi, Anna Maria Cafro, Elisabetta Tresoldi, Liliana Intropido, Michele Nichelatti, Laura Marbello, Claudia Baratè, Carlo Maurizio Camaggi, Enrica Morra, High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study, Cancer Chemotherapy and Pharmacology, 2007, 59, 6, 771

    CrossRef

  4. 4
    Janos Nadas, Duxin Sun, Anthracyclines as effective anticancer drugs, Expert Opinion on Drug Discovery, 2006, 1, 6, 549

    CrossRef

  5. 5
    Peter H. Wiernik, Plasma cell dyscrasias and leukemias, Update on Cancer Therapeutics, 2006, 1, 4, 539

    CrossRef

  6. 6
    Current Awareness in Hematological Oncology, Hematological Oncology, 2004, 22, 4
    Direct Link:
View Full Article (HTML) Get PDF (79K)